The Latest Breaking News from FDA

The U.S. Food and Drug Administration approved a gene therapy for dystrophic epidermolysis bullosa, also known as butterfly disease.

The Centres for Disease Control and Prevention (CDC) confirmed the number of patients treated for the drug-resistant strain of Pseudomonas aeruginosa has now risen to 81 patients in 18 states

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

Gene therapy has helped doctors make major strides in treating inherited blindness, and it's now being explored for other conditions.

Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.

Advocates say removing the barrier of prescriptions is long overdue

On Press Coverage In The Mifepristone Case.

Sunscreens work in two ways: either by blocking harmful UV rays from reaching the skin, or by converting the rays into heat that can be released from the body.